Novavax's Gregory Glenn, MD, talks about company's coronavirus vaccine candidate (Live 2/24)

preview_player
Показать описание
Gregory M. Glenn, MD, is the president of research and development at vaccine maker Novavax, whose COVID-19 vaccine candidate is the first to demonstrate clinical efficacy against the original coronavirus and both of the variants first identified in the U.K. and South Africa. If approved, the Novavax vaccine will be the first protein-based vaccine available, and the company is already working on an updated version of the vaccine to test against the new variants. Washington Post national health-care policy reporter Paige Winfield Cunningham interviews Glenn on Wednesday, Feb. 24 at 12:00pm ET.


Follow us:

#WashingtonPostLive #Novavax
Рекомендации по теме
Комментарии
Автор

Thanks to all the incredible work done by the team at Novavax! The world thanks you.

MitchRatner
Автор

When can we get it and where. The fact this vaccine has had time to be researched by the FDA is some what comforting, the others seemed rushed.

qmforever
Автор

If ivermectine passes trials and gets approved then emergency vaccines must get pulled

portaloocyprus
Автор

This vaccine is awesome. The idea is so neat that it is really beautiful (like bach..everything fits into place neatly). This in my opinion the best vaccine in the world right now. And even if the phase 3 trials are going on, I believe that it is worth it to get a jab.

sheeteshaswal
Автор

How do these people know C19 is gonna hang around? SARS 1 disappeared.

nicolajohnstone
Автор

Excellent interview! Talented interviewer- articulate guest!

lynnmckenna
Автор

Novavax accepts liability for vaccine industries. Yes or no.

lochinvar
Автор

Ah my mistake I forgot that their African study branch tested on previously infected persons as opposed to other vaccines not doing the same. That’s something super important to evaluate

armaniv
Автор

When will this be available in the US?

kathleenc
Автор

Where is the public concern with these deaths following vaccinations? I am fed up hearing correlation does not mean causation but at the very least they must be investigated. I am also stunned by the complete apathy regarding this situation from the Governments and the general public. We have shut society down and curtailed our freedoms to protect vulnerable aged groups but have very little reaction to sudden increase in deaths following vaccinations. I sometimes feel I am living in the twilight zone!

IbizaPlay
Автор

Does the Gates Foundation fund this company as well? Has this company been sued or had to pay out in fines for fraud?

nicolajohnstone
Автор

New research from Japan and spoken about by Dr Bridle is that they have discovered it is the spike protein that is toxic and causing issues by staying in the blood and getting into organs including ovaries. So, my question is, will this Novavax one be any different as it also uses spike protein?

nicolajohnstone
Автор

i wonder when we can have it in Canada ?

malekdaghighi
Автор

Sorry for the "after" and "vaccine" typos. Four strokes mane it hard to type. That, and other "co-morbidities" make all the more reasons I will take only the Novavax vaccine.

butcherlaw
Автор

I'm most excited about this protein based vaccine.

ZeeMan
Автор

Washington Post, can you NOT have your massive boxes of other videos blocking the text at 0:55 ?

cutelittlemoose
Автор

I wish to take Nvx -cov2373 as soon as it is available in the US. Praying for it's success and fast approval.

ruthblameuser
Автор

When will this be available in the uk 🇬🇧?.

jacquelinefoote
Автор

Is it killing people? What about cardiomyopathy or blood clots

kathleencorrente
Автор

But, there will be new variants by the time Novavax is available. So how effective will it be against those? For example against 167.1 etc.

goldlotus